Medtronic Medical Surgical — Reportable segment operating profit decreased by 6.0% to $499.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 34.8%, from $765.00M to $499.00M. Over 4 years (FY 2021 to FY 2025), Medical Surgical — Reportable segment operating profit shows a downward trend with a -13.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher operating profit indicates strong operational leverage and effective cost management within the segment.
The operating income generated by the Medical Surgical segment after deducting all direct operating expenses, including...
Standard segment operating income reported by peers in the medical technology industry.
mdt_segment_medical_surgical_reportable_segment_operating_profit| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $933.00M | $914.00M | $908.00M | $923.00M | $433.00M | $642.00M | $714.00M | $748.00M | $761.00M | $719.00M | $790.00M | $806.00M | $658.00M | $690.00M | $774.00M | $765.00M | $259.00M | $494.00M | $531.00M | $499.00M |
| QoQ Change | — | -2.0% | -0.7% | +1.7% | -53.1% | +48.3% | +11.2% | +4.8% | +1.7% | -5.5% | +9.9% | +2.0% | -18.4% | +4.9% | +12.2% | -1.2% | -66.1% | +90.7% | +7.5% | -6.0% |
| YoY Change | — | — | — | — | -53.6% | -29.8% | -21.4% | -19.0% | +75.8% | +12.0% | +10.6% | +7.8% | -13.5% | -4.0% | -2.0% | -5.1% | -60.6% | -28.4% | -31.4% | -34.8% |